Stephen Doral Stefani
Overview
Explore the profile of Stephen Doral Stefani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
18
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Peixoto R, Chakhtoura J, Aguilar-Ponce J, Garcia-Rivello H, Jansen A, Parra Medina R, et al.
Cureus
. 2024 Feb;
14(12):c83.
PMID: 38347938
[This corrects the article DOI: 10.7759/cureus.31972.].
2.
Horgan D, Hamdi Y, Lal J, Nyawira T, Meyer S, Kondji D, et al.
Healthcare (Basel)
. 2023 Feb;
11(3).
PMID: 36767006
Radical new possibilities of improved treatment of cancer are on offer from an advanced medical technology already demonstrating its significance: next-generation sequencing (NGS). This refined testing provides unprecedentedly precise diagnoses...
3.
Peixoto R, Chakhtoura J, Aguilar-Ponce J, Garcia-Rivello H, Jansen A, Parra Medina R, et al.
Cureus
. 2023 Jan;
14(11):e31972.
PMID: 36589179
The incidence of colorectal cancer in Argentina and Brazil has reached levels comparable to those in higher-income countries. Similarly, the incidence of melanoma in Latin America has increased during the...
4.
Horgan D, Hamdi Y, Lal J, Nyawira T, Meyer S, Kondji D, et al.
Diagnosis (Berl)
. 2022 Dec;
10(2):140-157.
PMID: 36548810
Objectives: The introduction of Personalised Medicine (PM) into healthcare systems could benefit from a clearer understanding of the distinct national and regional frameworks around the world. Recent engagement by international...
5.
Horgan D, Mia R, Erhabor T, Hamdi Y, Dandara C, Lal J, et al.
Healthcare (Basel)
. 2022 Nov;
10(11).
PMID: 36360466
Tackling cancer is a major challenge right on the global level. Europe is only the tip of an iceberg of cancer around the world. Prosperous developed countries share the same...
6.
Ferreira C, Achatz M, Ashton-Prolla P, Dirlei Begnami M, Marchini F, Stefani S
Lancet Oncol
. 2016 Aug;
17(8):e363-e370.
PMID: 27511160
A growing understanding of the molecular pathology of tumours combined with a surge of new drugs and associated diagnostic technologies (ie, precision medicine) has translated into substantial improvements in survival...
7.
Stefani S, Giorgio Saggia M, Vicino dos Santos E
J Med Econ
. 2009 May;
11(3):383-96.
PMID: 19450094
Objective: A cost-minimisation and budget impact analysis of erlotinib versus docetaxel or pemetrexed as second-line treatment for advanced non-small-cell lung cancer (NSCLC). Methods: Costs and budgetary impacts were estimated from...